| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
| 07/01/1997 | US5643747 Gene expression and cloning of bordetella genome and dna sequences |
| 07/01/1997 | US5643745 Heterologous dimeric proteins produced in heterokaryons |
| 07/01/1997 | US5643744 Condensation of amino acid and a nucleic acid adapter in presence of ribosomes and aromatic tertiary amine but no energy source such as atp or gtp |
| 07/01/1997 | US5643736 Hybridomas and detection of osteogenic cell subsets |
| 07/01/1997 | US5643735 Anti-thymosin α1 monoclonal antibody-producing hybridoma |
| 07/01/1997 | US5643722 Marking proteins and detection, incubation |
| 07/01/1997 | US5643714 Method and assay for HTLV |
| 07/01/1997 | US5643570 BPI-immunoglobulin fusion proteins |
| 07/01/1997 | US5643567 Antigrowth agents for tumors |
| 06/26/1997 | WO1997022712A1 NOVEL PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-β-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH¿2? |
| 06/26/1997 | WO1997022705A1 A FUNGUNS WHEREIN THE areA, pepC AND/OR pepE GENES HAVE BEEN INACTIVATED |
| 06/26/1997 | WO1997022704A1 Mitogen-activated protein kinase kinase mek6 and methods of use therefor |
| 06/26/1997 | WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 06/26/1997 | WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022623A1 Osteo antiviral protein |
| 06/26/1997 | WO1997022617A1 Methods for identifying compounds that bind to a target |
| 06/26/1997 | WO1997013845A3 Phosphopantetheinyl transferases and uses thereof |
| 06/26/1997 | DE19548222A1 Verfahren zur mikrobiellen Herstellung von Aminosäuren durch gesteigerte Aktivität von Exportcarriern Process for the microbial production of amino acids by increased activity of export carriers |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | DE19547933A1 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung Multimeric forms of IL-16, process for their preparation and use |
| 06/26/1997 | DE19547416A1 New monoclonal antibodies specific for proteosomes |
| 06/26/1997 | DE19547324A1 cDNA encoding human mucin 8 |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2240360A1 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
| 06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
| 06/26/1997 | CA2238995A1 Methods for identifying compounds that bind to a target |
| 06/25/1997 | EP0779933A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 06/25/1997 | EP0779932A1 Amino acid conjugate |
| 06/25/1997 | EP0779927A1 A method of improved production of insulin-like growth factor |
| 06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 06/25/1997 | EP0779896A1 New process for the production of biologically active protein |
| 06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 06/25/1997 | EP0623145B1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications |
| 06/25/1997 | EP0575443B1 Pea protein hydrolyzate, method for production thereof and use thereof |
| 06/25/1997 | CN1152942A N-terminally extended proteins expressed in yeast |
| 06/25/1997 | CN1152941A Genes for the synthesis of antipathogenic substances |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152939A Monoclonal antibodies which promote central nervous system remyelination |
| 06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/25/1997 | CN1152936A Granular formulation containing microorganisms, a process for the preparation and the use thereof |
| 06/25/1997 | CN1152935A Papillomavirus vaccines |
| 06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |
| 06/25/1997 | CN1152924A Proteins from mammaliam liver and their use in oncology |
| 06/25/1997 | CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 06/25/1997 | CN1152615A Process for preparing piptide acylate from protein of silk filature pupa by biological degradation |
| 06/25/1997 | CN1152439A Preparation process for full composition pearl crude liquid and pearl powder |
| 06/25/1997 | CN1035257C Midified plutelet factor-4 |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641874 DNA encoding bactericidal/permeability increasing proteins |
| 06/24/1997 | US5641870 Low pH hydrophobic interaction chromatography for antibody purification |
| 06/24/1997 | US5641869 Fractionation on immunoaffinity or ion exchange column, ethanol or ammonium sulfate precipitation, reverse phase liquid chromatography, chromatography on silica or heparin sepharose, chromatofocusing, gel filtration, electrophoresis |
| 06/24/1997 | US5641867 Antitumor agents |
| 06/24/1997 | US5641866 Bcl-2-associated proteins |
| 06/24/1997 | US5641865 Surfactant stabilized microheterogeneous dispersion of aqueous phase containing antibody or fragment thereof in water immiscible medium |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia |
| 06/24/1997 | US5641837 Method of detecting collagen degradation in vivo |
| 06/24/1997 | US5641760 Method of treating candida infection |
| 06/24/1997 | US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation |
| 06/24/1997 | US5641676 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 06/24/1997 | US5641672 Nucleic acid molecule; vectors; plasmids; host vector system |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641655 Genetic engineered dna encoding a protein fusion |
| 06/24/1997 | US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia |
| 06/24/1997 | US5641650 Expression of heterologous polypeptides in halobacteria |
| 06/24/1997 | US5641647 Serum free medium |
| 06/24/1997 | US5641646 Purification of fused protein and human glicentin is carried out by utilizing a reversible covalent bond of a cysteine residue with the stationary phase of a chromatography column |
| 06/24/1997 | US5641638 Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof |
| 06/24/1997 | US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
| 06/24/1997 | US5641485 Caledothricins used in the treatment mycotic diseases |
| 06/20/1997 | CA2193315A1 Human mucin (muc8) |
| 06/19/1997 | WO1997021829A1 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 06/19/1997 | WO1997021819A1 Novel nagpu |
| 06/19/1997 | WO1997021817A1 Antigenic protein originating in malassezia |
| 06/19/1997 | WO1997021813A1 Process for the purification of recombinant human interleukin-8 |
| 06/19/1997 | WO1997021812A2 Mammalian chemokine ccf8 and chemokine receptor cckr3 |
| 06/19/1997 | WO1997021811A2 Novel tyrosine kinase receptors and ligands |
| 06/19/1997 | WO1997021803A1 Aldolase catalytic antibody |
| 06/19/1997 | WO1997021488A1 Cell separation composition, kit and method |
| 06/19/1997 | WO1997016549A3 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 06/19/1997 | WO1997006256A3 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 06/19/1997 | WO1996024650A3 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
| 06/19/1997 | DE19548630A1 Verfahren zur Reinigung von rekombinantem Human-Interleukin - 8 A method for purification of recombinant human interleukin - 8 |
| 06/19/1997 | CA2240166A1 Process for the purification of recombinant human interleukin-8 |
| 06/18/1997 | EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses |
| 06/18/1997 | EP0779362A1 DNA constructs for endogenous gene activation and expression modification |
| 06/18/1997 | EP0778921A1 Pumping device |
| 06/18/1997 | EP0778893A2 Bacterial production of hydrophobic polypeptides |
| 06/18/1997 | EP0778892A1 Macrophage derived chemokine and chemokine analogs |